Caxton Corporation
VECT

Caxton Corporation’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Caxton Corporation’s Portfolio VECT Stock Details VECT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-156,651
Closed -$1.35M – 15
2023
Q1 		$1.35M Buy
156,651
+429
+0.3% +$3.54K 3.4% 6
2022
Q4 		$1.35M Buy
156,222
+15,359
+11% +$124K 3.44% 7
2022
Q3 		$845K Sell
140,863
-53,714
-28% -$292K 1.59% 12
2022
Q2 		$1.05M Buy
+194,577
New +$1.05M 1.41% 10

Other funds holding VECT

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CHI Advisors
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Glazer Capital LLC
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
UBS O'Connor
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Alpine Associates Management
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Versor Investments
Versor Investments New York $59.8M AUM 85.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Caxton Corporation's VECT Position: Q2 2023 in Review

Caxton Corporation sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q2 2023, closing a stake of 156,651 shares — an estimated $1.35M sold.

Caxton Corporation first reported a position in VECT in Q2 2022 and held it in 4 quarters. The position peaked at $1.35M in Q4 2022. 49 funds tracked by Wall St. Rank hold VECT as of Q2 2023.

  • Caxton Corporation reported no remaining VectivBio Holding AG Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • Caxton Corporation sold 156,651 VectivBio Holding AG Ordinary Shares shares in Q2 2023, an estimated $1.35M.
  • Caxton Corporation first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2022 and held it in 4 quarters.
  • Caxton Corporation's VectivBio Holding AG Ordinary Shares position peaked at $1.35M in Q4 2022.
  • 49 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q2 2023.

Based on Caxton Corporation's 13F filing for Q2 2023, filed 14 Aug 2023.